350 related articles for article (PubMed ID: 28041841)
1. ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.
Saladi SV; Ross K; Karaayvaz M; Tata PR; Mou H; Rajagopal J; Ramaswamy S; Ellisen LW
Cancer Cell; 2017 Jan; 31(1):35-49. PubMed ID: 28041841
[TBL] [Abstract][Full Text] [Related]
2. Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.
Chang CY; Shipony Z; Lin SG; Kuo A; Xiong X; Loh KM; Greenleaf WJ; Crabtree GR
Mol Cell; 2021 Dec; 81(24):4964-4978.e8. PubMed ID: 34687603
[TBL] [Abstract][Full Text] [Related]
3. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
Dang Y; Zhang L; Wang X
J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
[TBL] [Abstract][Full Text] [Related]
4. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.
Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X
Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063
[TBL] [Abstract][Full Text] [Related]
5. ACTL6A promotes the growth in non-small cell lung cancer by regulating Hippo/Yap pathway.
Ma L; Shan L
Exp Lung Res; 2021; 47(5):250-259. PubMed ID: 33896314
[No Abstract] [Full Text] [Related]
6. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.
Chai Y; Li Q; Zhao H; Zhang Z; Yu X; Pang L; Liu Z; Zhao J; Wang L; Li F
Cancer Med; 2019 Nov; 8(16):7055-7064. PubMed ID: 31560173
[TBL] [Abstract][Full Text] [Related]
7. ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
Xiao Y; Lin FT; Lin WC
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33408251
[TBL] [Abstract][Full Text] [Related]
8. ACTL6a enforces the epidermal progenitor state by suppressing SWI/SNF-dependent induction of KLF4.
Bao X; Tang J; Lopez-Pajares V; Tao S; Qu K; Crabtree GR; Khavari PA
Cell Stem Cell; 2013 Feb; 12(2):193-203. PubMed ID: 23395444
[TBL] [Abstract][Full Text] [Related]
9. ACTL6A suppresses p21
Shrestha S; Adhikary G; Xu W; Kandasamy S; Eckert RL
Oncogene; 2020 Sep; 39(36):5855-5866. PubMed ID: 32616890
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex.
Verduci L; Ferraiuolo M; Sacconi A; Ganci F; Vitale J; Colombo T; Paci P; Strano S; Macino G; Rajewsky N; Blandino G
Genome Biol; 2017 Dec; 18(1):237. PubMed ID: 29262850
[TBL] [Abstract][Full Text] [Related]
11. MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling.
Zhao J; Li L; Yang T
J Cell Physiol; 2020 Dec; 235(12):9718-9728. PubMed ID: 32401366
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA uc.291 controls epithelial differentiation by interfering with the ACTL6A/BAF complex.
Panatta E; Lena AM; Mancini M; Smirnov A; Marini A; Delli Ponti R; Botta-Orfila T; Tartaglia GG; Mauriello A; Zhang X; Calin GA; Melino G; Candi E
EMBO Rep; 2020 Mar; 21(3):e46734. PubMed ID: 32017402
[TBL] [Abstract][Full Text] [Related]
13. Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway.
Zhou Y; Xu Q; Tao L; Chen Y; Shu Y; Wu Z; Lu C; Shi Y; Bu H
Clin Sci (Lond); 2020 Jun; 134(12):1457-1472. PubMed ID: 32514535
[TBL] [Abstract][Full Text] [Related]
14. Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis.
Ge L; Smail M; Meng W; Shyr Y; Ye F; Fan KH; Li X; Zhou HM; Bhowmick NA
PLoS One; 2011; 6(11):e27529. PubMed ID: 22096589
[TBL] [Abstract][Full Text] [Related]
15. Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer.
Faraji F; Ramirez SI; Anguiano Quiroz PY; Mendez-Molina AN; Gutkind JS
Cells; 2022 Apr; 11(8):. PubMed ID: 35456049
[TBL] [Abstract][Full Text] [Related]
16. The genetic alteration spectrum of the SWI/SNF complex: The oncogenic roles of BRD9 and ACTL6A.
Sima X; He J; Peng J; Xu Y; Zhang F; Deng L
PLoS One; 2019; 14(9):e0222305. PubMed ID: 31504061
[TBL] [Abstract][Full Text] [Related]
17. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.
Martin D; Degese MS; Vitale-Cross L; Iglesias-Bartolome R; Valera JLC; Wang Z; Feng X; Yeerna H; Vadmal V; Moroishi T; Thorne RF; Zaida M; Siegele B; Cheong SC; Molinolo AA; Samuels Y; Tamayo P; Guan KL; Lippman SM; Lyons JG; Gutkind JS
Nat Commun; 2018 Jul; 9(1):2372. PubMed ID: 29985391
[TBL] [Abstract][Full Text] [Related]
18. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
[TBL] [Abstract][Full Text] [Related]
19. The potential role of YAP in head and neck squamous cell carcinoma.
Shin E; Kim J
Exp Mol Med; 2020 Aug; 52(8):1264-1274. PubMed ID: 32859951
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
